Tato stránka byla automaticky přeložena a přesnost překladu není zaručena. Podívejte se prosím na anglická verze pro zdrojový text.

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System ((JJ-TRAILS))

22. července 2019 aktualizováno: Michael L. Dennis, Ph.D., Chestnut Health Systems

Juvenile Justice Translational Research on Interventions for Adolescents in the Legal System: Multi-site Implementation Study

This is a multi site experiment to evaluate the impact of various strategies for increasing the use of evidence based screening, assessment and linkage to substance use treatment. All sites collect baseline data and receive a core intervention. Half are then randomly assigned to get an additional year of coaching to facilitate implementation.

Přehled studie

Postavení

Dokončeno

Detailní popis

Background: The Juvenile Justice-Translational Research on Interventions for Adolescents in the Legal System (JJ-TRIALS) study is a cooperative implementation science initiative involving the National Institute on Drug Abuse, six Research Centers, a Coordinating Center, and Juvenile Justice Partners representing seven U.S. states. The pooling of resources across Centers enables a robust implementation study design involving 36 juvenile justice agencies and their behavioral health partner agencies, coproducing a study protocol that has potential to advance implementation science, meets the needs of all constituencies (funding agency, researchers, partners, study sites), and can be implemented with fidelity across the cooperative can be challenging.

Methods/design: The JJ-TRIALS primary study uses a head-to-head cluster randomized trial with a phased rollout to evaluate the differential effectiveness of two conditions (Core and Enhanced) in 36 sites located in 7 states. Core strategies for promoting change are compared to an Enhanced strategy that incorporate all core strategies plus active facilitation. Target outcomes include improvements in evidence-based screening, assessment, and linkage to substance use treatment.

Primary Research Questions:

  1. Does the Core and/or Enhanced Intervention reduce unmet need by increasing Cascade retention related to screening, assessment, treatment initiation, engagement and continuing care?
  2. Does the addition of the Enhanced Intervention components further increase the percentage of youth retained in the Cascade relative to the Core components?
  3. Does the addition of the Enhanced Intervention components improve service quality relative to Core sites?
  4. Do staff perceptions of the value of best practices increase over time, and are increases more pronounced in Enhanced sites?

Typ studie

Intervenční

Zápis (Aktuální)

839

Fáze

  • Nelze použít

Kontakty a umístění

Tato část poskytuje kontaktní údaje pro ty, kteří studii provádějí, a informace o tom, kde se tato studie provádí.

Studijní místa

    • Georgia
      • Atlanta, Georgia, Spojené státy, 30322
        • Emory University
    • Illinois
      • Bloomington, Illinois, Spojené státy, 61701
        • Chestnut Health Systems
    • Kentucky
      • Lexington, Kentucky, Spojené státy, 40508
        • University of Kentucky
    • Maryland
      • Rockville, Maryland, Spojené státy, 20892
        • National Institute on Drug Abuse
    • Mississippi
      • Starkville, Mississippi, Spojené státy, 39759
        • Mississippi State University
    • New York
      • New York, New York, Spojené státy, 10032
        • Columbia University
    • Pennsylvania
      • Philadelphia, Pennsylvania, Spojené státy, 19122
        • Temple University
    • Texas
      • Fort Worth, Texas, Spojené státy, 76129
        • Texas Christian University

Kritéria účasti

Výzkumníci hledají lidi, kteří odpovídají určitému popisu, kterému se říká kritéria způsobilosti. Některé příklady těchto kritérií jsou celkový zdravotní stav osoby nebo předchozí léčba.

Kritéria způsobilosti

Věk způsobilý ke studiu

  • Dítě
  • Dospělý
  • Starší dospělý

Přijímá zdravé dobrovolníky

Ne

Pohlaví způsobilá ke studiu

Všechno

Popis

Specific site inclusion criteria include: (a) ability to provide youth service records, (b) service to youth under community supervision, (c) access to treatment provider(s) if treatment is not provided directly by the JJ agency, (d) participation in requisite intervention training/activities,(e) minimum average case flow of 10 youth per month, (f) minimum of 10 staff per site, and (g) a senior JJ staff member who agrees to serve as site leader/liaison during the study. Study sites are geographically dispersed and were identified by state JJ agencies (and not selected for particular substance use or related BH service needs).

Youth inclusion criteria include: all youth entering the juvenile justice system during the period within the exception of those who are already in treatment at the time that they are referred to the juvenile justice agency.

Staff inclusion criteria include: all staff actively working with the youth under community supervision in the site with exclusion only of higher level administrative or regional staff over multiple units..

Studijní plán

Tato část poskytuje podrobnosti o studijním plánu, včetně toho, jak je studie navržena a co studie měří.

Jak je studie koncipována?

Detaily designu

  • Primární účel: Výzkum zdravotnických služeb
  • Přidělení: Randomizované
  • Intervenční model: Paralelní přiřazení
  • Maskování: Trojnásobný

Zbraně a zásahy

Skupina účastníků / Arm
Intervence / Léčba
Žádný zásah: Control
During the Baseline Control data is collected in all 36 sites at the agency, staff, and youth level on the 6 months prior to the interventions in Arms 2 & 3 to document what practice was before the study.
Aktivní komparátor: Core

In the second phase (after baseline) all 36 sites receive a Core condition that includes five interventions: (1) JJ-TRIALS Orientation Meetings, (2) Needs Assessment, (3) Behavioral Health Training, (4) Site Feedback Report, (5) Goal Achievement Training, (6) Monthly Site Check-ins, and (7) Quarterly Reports. As part of Goal Achievement Training, sites receive assistance in using their Site Feedback Reports to select goals to meet their local needs. Sites are trained on using Data-Driven Decision Making (DDDM) to inform decisions (e.g., selecting a goal, monitoring progress) and enlisting DDDM templates and tools (developed as part of the project) to plan and implement proposed changes.

these principles to their improvement efforts during the implementation phase.

Ostatní jména:
  • GAT, DDDM
Experimentální: Enhanced
While the core intervention and DDDM are expected to facilitate change, organizations may need additional support to apply these principles to their improvement efforts during the implementation phase. In the third phase (after Core), 1/2 of the sites are randomly assigned to an Enhanced condition that provides continuing support for the use of DDDM tools by adding research staff facilitation of DDDM over a 12-month period and formalized Local Change Teams (LCTs) featuring representation from the JJ agency and a local BH provider, with meetings facilitated by research staff).
Ostatní jména:
  • GAT, DDDM
Ostatní jména:
  • DDDM, Facilitation

Co je měření studie?

Primární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Service Cascade: % Referred to Substance Use Treatment
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth referred to substance use treatment divided by the number of youth identified as need of substance use treatment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Treatment
Časové okno: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use treatment services.
120 weeks

Sekundární výstupní opatření

Měření výsledku
Popis opatření
Časové okno
Service Cascade: % Screened for Substance Use Problems
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Screened" for substance use problems divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % Clinically Assessed for Substance Use Problems
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Clinically Assessed" for substance use problems divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % In Need of Substance Use Treatment
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth identified (via screening, clinical assessment or other sources) as "In Need of Substance Use Treatment" divided by the number of youth entering the juvenile justice system.
120 weeks
Service Cascade: % Initiating Substance Use Treatment
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Initiating" Substance Use Treatment within 90 days of referral" divided by the number referred to treatment from the juvenile justice system.
120 weeks
Service Cascade: % Engaged in Substance Use Treatment
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the number of youth "Engaged" in Substance Use Treatment for 6 weeks or more weeks divided by the number initiating treatment.
120 weeks
Service Cascade: % With Substance Use Treatment Continuing Care
Časové okno: 120 weeks
number of youth "Continuing" to receive substance use treatment services forCalculated from juvenile justice and substance use treatment agency records as the 90 days or more divided by the number initiating treatment.
120 weeks
Service Quality: Timing of Screening or Clinical Assessment
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the mean days from entry into the justice system to the first of screening or clinical assessment for substance use problems.
120 weeks
Service Quality: Timing of Substance Use Treatment Initiation
Časové okno: 120 weeks
Calculated from juvenile justice and substance use treatment agency records as the mean days from referral to and initiation of substance use treatment.
120 weeks
Service Quality: Number of Evidence Based Practices
Časové okno: 120 Weeks
Based on agency surveys and youth records from juvenile justice and substance use treatment agencies, the number of steps using 1 or more evidenced based practices in each of the following steps along the service cascade: screening, clinical assessment, referral, substance use treatment.
120 Weeks
Staff Perception: Value of Evidenced Based Screening
Časové okno: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based screening.
120 weeks
Staff Perception: Value of Evidenced Based Clinical Assessment
Časové okno: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based clinical assessment.
120 weeks
Staff Perception: Value of Evidenced Based Substance Use Prevention
Časové okno: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based substance use prevention.
120 weeks
Staff Perception: Value of Evidenced Based HIV Risk Prevention
Časové okno: 120 weeks
Calculated from staff surveys at juvenile justice and substance use treatment agencies as the average staff ranking of the perceived "value" of using of evidence-based HIV Risk prevention.
120 weeks

Spolupracovníci a vyšetřovatelé

Zde najdete lidi a organizace zapojené do této studie.

Vyšetřovatelé

  • Vrchní vyšetřovatel: Christy K Scott, Ph.D., Chestnut Health Systems
  • Vrchní vyšetřovatel: Danica K Knight, Ph.D., Texas Christian University
  • Vrchní vyšetřovatel: Michael L Dennis, Ph.D., Chestnut Health Systems
  • Vrchní vyšetřovatel: Tisha R Wiley, Ph.D., National Institute on Drug Abuse (NIDA)
  • Vrchní vyšetřovatel: Gail A Wasserman, Ph.D., Columbia University
  • Vrchní vyšetřovatel: Ralph DiClemente, Ph.D., Emory University
  • Vrchní vyšetřovatel: Gene H Brody, Ph.D., Emory University
  • Vrchní vyšetřovatel: Angela A Robertson, Ph.D., Mississippi State University
  • Vrchní vyšetřovatel: Steven R Belenko, Ph.D., Temple University
  • Vrchní vyšetřovatel: Carl G Leukefeld, Ph.D., University of Kentucky

Publikace a užitečné odkazy

Osoba odpovědná za zadávání informací o studiu tyto publikace poskytuje dobrovolně. Mohou se týkat čehokoli, co souvisí se studiem.

Obecné publikace

Užitečné odkazy

Termíny studijních záznamů

Tato data sledují průběh záznamů studie a předkládání souhrnných výsledků na ClinicalTrials.gov. Záznamy ze studií a hlášené výsledky jsou před zveřejněním na veřejné webové stránce přezkoumány Národní lékařskou knihovnou (NLM), aby se ujistily, že splňují specifické standardy kontroly kvality.

Hlavní termíny studia

Začátek studia (Aktuální)

1. července 2013

Primární dokončení (Aktuální)

31. ledna 2019

Dokončení studie (Aktuální)

30. června 2019

Termíny zápisu do studia

První předloženo

22. ledna 2016

První předloženo, které splnilo kritéria kontroly kvality

29. ledna 2016

První zveřejněno (Odhad)

3. února 2016

Aktualizace studijních záznamů

Poslední zveřejněná aktualizace (Aktuální)

23. července 2019

Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality

22. července 2019

Naposledy ověřeno

1. července 2019

Více informací

Termíny související s touto studií

Další identifikační čísla studie

  • JJ-TRIALS
  • U01DA036221 (Grant/smlouva NIH USA)
  • U01DA036226 (Grant/smlouva NIH USA)
  • U01DA036233 (Grant/smlouva NIH USA)
  • U01DA036176 (Grant/smlouva NIH USA)
  • U01DA036225 (Grant/smlouva NIH USA)
  • U01DA036224 (Grant/smlouva NIH USA)
  • U01DA036158 (Grant/smlouva NIH USA)

Plán pro data jednotlivých účastníků (IPD)

Plánujete sdílet data jednotlivých účastníků (IPD)?

ANO

Popis plánu IPD

The coordinating center is charged with creating de-identified versions of agency, staff and client level service data available at the end of the study.

Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .

Předplatit